MELD（终末期肝病模型）评分

预约门诊
打印

妙佑医疗国际的方法

  • 您的妙佑医疗国际医护团队。 妙佑医疗国际的多学科专科医生团队通力合作，对每位患者进行评估和治疗。妙佑医疗国际胃肠病科和肝脏病科配备 13 个专科团队和 140 多位消化道疾病专科医生，是世界上规模最大且经验最丰富的科室之一。
  • 先进的诊断与治疗。 肝硬化的精准诊断和分期对指导治疗至关重要。妙佑医疗国际的研究人员发明了磁共振弹性成像，这是一种可绘制肝脏硬化图谱的无创检查。这种最先进的成像技术可帮助妙佑医疗的专科医生及早查出肝病，让患者有机会尽早开始治疗，并帮助改善治疗结局。正在妙佑医疗国际接受治疗的患者也是首批从妙佑医疗的新成果中获益的人。
  • 专注于患者的治疗。 妙佑医疗国际的医生会与您一起确定哪种预防策略最能满足您的需求和意愿。如果您需要进行肝移植，由妙佑医疗国际的外科医生、医生、移植护士、药剂师、社工和其他医疗护理专业人员组成的团队会在移植之前、期间和之后为您提供医护服务。他们围绕您和您家人的需求，提供优质医护服务。

医生也可能帮助您确定您是否有资格参加针对终末期肝病患者进行的临床试验或研究。

在妙佑医疗国际的体验与患者故事

患者告诉我们，互动质量、关注细节以及就医效率都是他们从未经历过的医疗体验。查看妙佑医疗国际满意患者的故事。

专长与排名

创新和研究

亚利桑那州院区、佛罗里达州院区和明尼苏达州院区的肝移植团队是心脏肝移植、肝癌患者移植和使用抗排斥药物以确保积极结果方面的领导者和创新者。许多有棘手健康问题的患者来到妙佑医疗国际寻求帮助，这是因为妙佑医疗的医生和外科医生都是专门从事肝移植方案（包括活供体肝移植）的专家。

移植专业技能

妙佑医疗国际移植中心为许多肝移植研究提供支持。例如，妙佑医疗国际的研究人员正在研发一种生物人工肝脏，可以帮助患者在等待供体肝脏时应对自己的疾病。妙佑医疗国际的肝移植结果优于全国平均水平。

妙佑医疗国际亚利桑那州院区

妙佑医疗国际佛罗里达州院区

妙佑医疗国际明尼苏达州院区

妙佑区域医疗系统

伦敦妙佑医疗中心

有关账单和保险的更多信息：

妙佑医疗国际亚利桑那州、佛罗里达州以明尼苏达州院区

妙佑区域医疗系统

来自妙佑医疗国际员工
申请预约
医生与科室
Jan. 13, 2026
打印
  1. Guo G, et al. The development and appraisal of MELD 3.0 in liver diseases: Good things never come easy. Journal of Clinical Translational Hepatology. 2024; doi:10.14218/JCTH.2020.00303.
  2. Kim WR, et al. MELD 3.0: The model for end-stage liver disease updated for the modern era. Gastroenterology. 2021; doi:10.1053/j.gastro.2021.08.050.
  3. A guide to taking warfarin. American Heart Association. https://www.heart.org/en/health-topics/arrhythmia/prevention--treatment-of-arrhythmia/a-patients-guide-to-taking-warfarin. Accessed July 25, 2025.
  4. Wang Y, et al. Increased INR values predict accelerating deterioration and high short-term mortality among patients hospitalized with cirrhosis or advanced fibrosis. Frontiers. 2021; doi:10.3389/fmed.2021.762291.
  5. Creatinine. National Kidney Foundation. https://www.kidney.org/kidney-topics/creatinine. Accessed July 28, 2025.
  6. Casciola R, et al. Creatine supplementation to improve sarcopenia in chronic liver disease: Facts and perspectives. Nutrients. 2023; doi:10.3390/nu15040863.
  7. Guerra Ruiz AR, et al. Measurement and clinical usefulness of bilirubin in liver disease. Advances in Laboratory Medicine. 2021; doi:10.1515/almed-2021-0047.
  8. Lenci I, et at. Natremia and liver transplantation: The right amount of salt for a good recipe. World Journal of Hepatology. 2020; doi:10.4254/wjh.v12.i11.919.
  9. Edema (swelling) and cancer treatment. National Cancer Institute. https://www.cancer.gov/about-cancer/treatment/side-effects/edema. Accessed July 28, 2025.
  10. Nouraie M, et al. Serum albumin is independently associated with higher mortality in adult sickle cell patients: Results of three independent cohorts. PLOS One. 2020; doi:10.1371/journal.pone.0237543.
  11. Dale E, et al. Inconsistent values and algorithmic fairness: a review of organ allocation priority systems in the United States. BMC Medical Ethics. 2024; doi:10.1186/s12910-024-011.
  12. Becchetti C, et al. Sex-based disparities in liver transplantation: Evidence from a nationwide Italian cohort. JHEP Reports. 2025; doi:10.1016/j.jhepr.2025.101387.
  13. Bambha K, et al. Model for end-stage liver disease (MELD). https://www.uptodate.com/contents/search. Accessed Aug. 7, 2025.
  14. Bednar R, et al. Low back pain in patients hospitalised with liver cirrhosis — A retrospective study. BMC Musculoskeletal Disorders. 2023; doi:10.1186/s12891-023-06424-8.
  15. Forna L, et al. Pediatric perspectives on liver cirrhosis: Unravelling clinical patterns and therapeutic challenges. Journal of Clinical Medicine. 2024; doi:10.3390/jcm13144275.
  16. Yun G, et al. Evaluation and management of hypernatremia in adults: clinical perspectives. Korean Journal of Internal Medicine. 2022; doi:10.3904/kjim.2022.346.
  17. Gines P, et al. Liver cirrhosis. The Lancet. 2021; doi:10.1016/S0140-6736(21)01374-X.
  18. Alcohol-associated liver disease. American Liver Foundation. https://liverfoundation.org/liver-diseases/alcohol-associated-liver-disease/#1507302760988-870375fd-f7al. Accessed Aug. 7, 2025.
  19. Questions and answers about liver allocation. Organ Procurement and Transplantation Network. https://optn.transplant.hrsa.gov/patients/by-organ/liver/questions-and-answers-about-liver-allocation. Accessed Aug. 7, 2025.
  20. Puri P, et al. Liver transplantation: Contraindication and ineligibility. Journal of Clinical and Experimental Hepatology. 2023; doi:10.1016/j.jceh.2023.04.005.
  21. Luo Z, et al. MELD as a metric for survival benefit of liver transplantation. American Journal of Transplantation. 2018; doi:10.1111/ajt.14660.
  22. Ge J, et al. "Beyond MELD" — Emerging strategies and technologies for improving mortality prediction, organ allocation and outcomes in liver transplantation. Journal of Hepatology. 2022; doi:10.1016/j.jhep.2022.03.003.
  23. Ni K, et al. MELD score reflects the mood, sleep, and daily living ability in liver transplantation candidates: A descriptive study. Annals of Transplantation. 2020; doi:10.12659/AOT.926857.
  24. Kiene SM, et al. Efficacy of an enhanced linkage to HIV care intervention at improving linkage to HIV care and achieving viral suppression following home-based HIV testing in rural Uganda: Study protocol for the Ekkubo/PATH cluster randomized controlled trial. BMC Infectious Diseases. 2017; doi:10.1186/s12879-017-2537-z.
  25. Bendersky VA, et al. The evolving role of liver transplantation for metastatic colorectal cancer: current perspectives and future directions. Frontiers in Surgery. 2025; doi:10.3389/fsurg.2025.1608467.
  26. Cameron JL, et al. Liver transplantation. In: Current Surgical Therapy. 14th ed. Elsevier; 2023. https://www.clinicalkey.com. Accessed Aug. 19, 2025.
  27. Goldstein NE, et al. What are the causes and complications of chronic liver disease and what is the evidence for palliative care delivery to those affected by it? In: Evidence-Based Practice of Palliative Medicine. 2nd ed. Elsevier; 2023. https://www.clinicalkey.com. Accessed Aug. 20, 2025.
  28. MELD calculator. Mayo Clinic. https://www.mayoclinic.org/medical-professionals/transplant-medicine/calculators/meld-model/itt-20434705. Accessed Aug. 20, 2025.
  29. MELD score and 90-day mortality rate for alcoholic hepatitis. Mayo Clinic. https://www.mayoclinic.org/medical-professionals/transplant-medicine/calculators/meld-score-and-90-day-mortality-rate-for-alcoholic-hepatitis/itt-20434719. Accessed Aug. 20, 2025.
  30. Learn about MELD. Organ Procurement and Transplantation Network. https://optn.transplant.hrsa.gov/data/allocation-calculators/meld-calculator/learn-about-meld. Accessed Aug. 20, 2025.
  31. MELD scores and mortality. Merck Manual Professional Version. https://www.merckmanuals.com/professional/multimedia/table/meld-scores-and-mortality. Accessed Aug. 20, 2025.
  32. Liver transplant. Mayo Clinic. https://www.mayoclinic.org/tests-procedures/liver-transplant/about/pac-20384842. Accessed Sept. 25, 2025.
  33. Cirrhosis. Mayo Clinic. https://www.mayoclinic.org/diseases-conditions/cirrhosis/symptoms-causes/syc-20351487. Accessed Sept. 25, 2025.

相关

Mayo Clinic 新闻

MELD（终末期肝病模型）评分